The S.E.C. alleged shortcomings in research said to support the drug, and its developer agreed to a $40 million settlement.

Scientists say they have achieved a "first" in the development of drugs to treat Alzheimer's disease. In a study published in the journal Alzheimer's & Dementia, a team of researchers report the ...

An international team of researchers have made a promising breakthrough in the development of drugs to treat Alzheimer's Disease. For the first time, scientists have developed a drug that works on ...

An international team of researchers led by Lancaster University has made a promising breakthrough in the development of ...

Researchers believe their work will have a significant impact on drug discovery efforts in the field of neurodegenerative ...

Scientists have developed a drug that targets both major aggregation-promoting sites of the Tau protein, a key player in ...

Researchers say a new drug could stop Alzheimer's in its tracksResearchers have hailed a promising breakthrough in the ...

The research, published in Alzheimer's & Dementia ... we have a drug which is effective in inhibiting both these regions. This dual-targeting mechanism is significant because it addresses both ...

AG03, targets two key areas of the Tau protein in Alzheimer's disease, showing effectiveness in lab and fruit fly models.

These new immunotherapy drugs trigger the body’s immune system to break ... although evidence on their effectiveness is limited. “We think that the mechanism of vascular dementia is increasing ...

Numerous mechanisms have been found linking dementia and type 2 diabetes, including vascular compromise, hypoglycemia, and insulin resistance. Therefore, anti-glycemic drugs could potentially have ...